InsiderClue
Insiders · Profile

Galbraith Kenneth

Chair & CEO at Zymeworks · Director at MACROGENICS. Filing since 16 Oct 2013. CIK 0001567045

ZYME Zymeworks Inc. Chair & CEO · 6 trades MGNX MACROGENICS INC Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ZYME Zymeworks Inc.
12 Jan 2026
Chair & CEO
Sold at will
30,424
$689.82K
11.8%
ZYME Zymeworks Inc.
5 Jan 2026
Chair & CEO
Sold at will
54,343
$1.36M
25.6%
ZYME Zymeworks Inc.
22 Dec 2025
Chair & CEO
Sold at will
47,528
$1.28M
26.3%
ZYME Zymeworks Inc.
6 Jan 2025
Chair & CEO
Sold at will
57,291
$855.02K
54.6%
ZYME Zymeworks Inc.
8 Jan 2024
Chair & CEO
Sold at will
5,706
$64.00K
19.4%
ZYME Zymeworks Inc.
5 Jan 2024
Chair & CEO
Sold at will
18,198
$193.85K
38.2%
MGNX MACROGENICS INC
9 Sep 2020
Director
Sold, plan not stated
20,773
$563.16K
100%
MGNX MACROGENICS INC
16 Oct 2013
Director
Bought
46,875
$750.00K
opened
8 decisions on file.